Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1938 Oct 31;68(5):703-24.
doi: 10.1084/jem.68.5.703.

IMMUNOLOGICAL REACTIONS WITH A VIRUS CAUSING PAPILLOMAS IN RABBITS : I. DEMONSTRATION OF A COMPLEMENT FIXATION REACTION: RELATION OF VIRUS-NEUTRALIZING AND COMPLEMENT-BINDING ANTIBODIES

Affiliations

IMMUNOLOGICAL REACTIONS WITH A VIRUS CAUSING PAPILLOMAS IN RABBITS : I. DEMONSTRATION OF A COMPLEMENT FIXATION REACTION: RELATION OF VIRUS-NEUTRALIZING AND COMPLEMENT-BINDING ANTIBODIES

J G Kidd. J Exp Med. .

Abstract

The sera of rabbits bearing virus-induced papillomas have been found to bind complement when mixed with antigens consisting of extracts or filtrates of the growths containing the virus. The sera of normal rabbits, of those immune to other viruses (vaccinia, herpes, fibroma, myxoma), of rabbits with syphilis, or of those with papillomas consequent on tarring, did not fix complement upon admixture with the papilloma antigens. The complement-binding antibody was present in the serum specimens in the same relative proportions as the virus-neutralizing antibody, and both were present in greatest amount in the sera of rabbits that had borne large papillomas over considerable periods of time. A few sera were come upon that neutralized small amounts of the virus yet failed to bind complement to any noteworthy degree in the tests. The sera of cottontail rabbits fixed complement and neutralized the virus in much higher titer than the sera of domestic rabbits with comparable growths. The implications of the findings will be discussed in a subsequent paper, after the properties of the complement-binding antigen have been scrutinized.

PubMed Disclaimer

References

    1. J Exp Med. 1933 Oct 31;58(5):607-24 - PubMed
    1. J Exp Med. 1934 Nov 30;60(6):723-40 - PubMed